Bengal Physician Journal

Register      Login

VOLUME 11 , ISSUE 2 ( May-August, 2024 ) > List of Articles

Correspondence

Role of ABO Blood Group and Hematological Parameters in COVID-19 Prediction

Falah Hasan O AL-Khikani

Keywords : ABO blood group, COVID-19, Hematological parameters

Citation Information : AL-Khikani FH. Role of ABO Blood Group and Hematological Parameters in COVID-19 Prediction. Bengal Physician Journal 2024; 11 (2):87-88.

DOI: 10.5005/jp-journals-10070-8030

License: CC BY-NC 4.0

Published Online: 06-07-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

PDF Share
  1. Al-Khikani FH. The role of blood group in COVID-19 infection: More information is needed. J Nature Sci Med 2020;3:225–226. DOI: 10.4103/JNSM.JNSM_24_20.
  2. Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev 2015;28(3):801–870. DOI: 10.1128/CMR.00109-14.
  3. Ad'hiah AH, Allami RH, Mohsin RH, et al. Evaluating of the association between ABO blood groups and coronavirus disease 2019 (COVID-19) in Iraqi patients. Egyptian Journal of Medical Human Genetics 2020;21:1–6. DOI: 10.1186/s43042-020-00097-x.
  4. Al-Khikani FH, Al-Hussainy AD, Hussein AZ, et al. SARS-CoV-2 and Helicobacter pylori and some hematological parameters: A case–control study. Journal of Medical Society 2022;36:129–133. DOI: 10.4103/jms.jms_55_22.
  5. Behera B, Rout B, Rajashree Panigrahy, et al. ABO blood grouping and COVID-19: A hospital-based study in Eastern India. Egypt J Med Hum Genet 2022;23(1):7. DOI: 10.1186/s43042-022-00225-9.
  6. Rios M, Bianco C. The role of blood group antigens in infectious diseases. Semin Hematol 2000;37(2):177–185. WB Saunders. DOI: 10.1016/s0037-1963(00)90042-8.
  7. Zhao J, Yang Y, Huang H, et al. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis 2021;73(2):328–331. DOI: 10.1093/cid/ciaa1150.
  8. Storry JR, Olsson ML. The ABO blood group system revisited: A review and update. Immunohematology 2009;25:48–59. PMID: 19927620.
  9. Jing W, Zhao S, Liu J, et al. ABO blood groups and hepatitis B virus infection: A systematic review and meta-analysis. BMJ Open 2020;10:87. DOI: 10.1136/bmjopen-2019-034114.
  10. AL-Khikani FH, Kadim MM. Association between presepsin, C-reactive protein (CRP), lactate dehydrogenase (LDH) and prognosis of COVID-19. Microbes Infect Dis 2023;4:1126–1132. DOI: 10.21608/mid.2023.226207.1577.
  11. Cheng Y, Cheng G, Chui CH, et al. ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA 2005;293:1447–1451. DOI: 10.1001/jama.293.12.1450-c.
  12. AL-Khikani FH. Impact of IL-35 and presepsin on immunological, hematological, and biochemical parameters in COVID-19 patients. Infect Epidemiol Microbiol 2023;9:89. DOI: 10.52547/iem.9.1.35.
  13. Blomme S, Smets L, Van Ranst M, et al. The influence of COVID-19 on routine hematological parameters of hospitalized patients. Acta Clinica Belgica 2022;77:241–246. DOI: 10.1080/17843286.2020. 1814649.
  14. AL-Khikani FH, Alkhafaji ZA. A scoping review of SARS-CoV-2 diagnosis: Current options and future aspects. Microbes and Infectious Diseases 2023;5:29. DOI: 10.21608/MID.2023.204730.1505.
  15. Jalil AT, Shanshool MT, Dilfy SH, et al. Hematological and serological parameters for detection of COVID-19. Journal of Microbiology, Biotechnology and Food Sciences 2022;11:e4229. DOI: 10.55251/jmbfs.4229.
  16. AL-Khikani FH. Interleukin-35, D-dimer, and ferritin as mortality predictive in SARS-COV-2. Microbes Infect Dis 2023;4:729–734. DOI: 10.21608/MID.2023.214752.1532.
  17. Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol 2020;84:106504. DOI: 10.1016/j.intimp.2020.106504.
  18. Saurabh A, Dey B, Raphael V, et al. Evaluation of hematological parameters in predicting intensive care unit admission in COVID-19 patients. SN Compr Clin Med 2022;4(1):39. DOI: 10.1007/s42399-021-01115-8.
  19. Falah AK, Hameed R. COVID-19 treatment: Possible role of itraconazole as new therapeutic option. Int J Health Allied Sci 2020;9:101. DOI: 10.4103/ijhas.IJHAS_64_20.
  20. Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020;382:1708–1720. DOI: 10.1056/NEJMoa2002032.
  21. Al-Khikani FHO, Alkhafaji ZA. The rs568408 variant in the IL-12A gene is associated with risk for COVID-19 in Iraqi patients. Tzu Chi Med J 2022;35(2):152–157. DOI: 10.4103/tcmj.tcmj_223_22.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.